Comprehensive alpha, beta and delta cell transcriptomes reveal that ghrelin selectively activates delta cells and promotes somatostatin release from pancreatic islets

Molecular Metabolism

Volumn 5, Issue 7, 2016, Pages 449-458

  DiGruccio, Michael R ^a   Mawla, Alex M ^a   Donaldson, Cynthia J ^b   Noguchi, Glyn M ^a   Vaughan, Joan ^b   Cowing Zitron, Christopher ^a   van der Meulen, Talitha ^a   Huising, Mark O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Alpha cell; Beta cell; Delta cell; Ghrelin; Somatostatin release; Transcriptome

Indexed keywords

GHRELIN; SOMATOSTATIN; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET DELTA CELL; PRIORITY JOURNAL; SOMATOSTATIN RELEASE;

EID: 84966703629     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2016.04.007     Document Type: Article

References (50)

1. Caicedo A. Paracrine and autocrine interactions in the human islet: more than meets the eye. Seminars in Cell & Developmental Biology 2013, 24(1):11-21.
2. Yang Y.H., Szabat M., Bragagnini C., Kott K., Helgason C.D., Hoffman B.G., et al. Paracrine signalling loops in adult human and mouse pancreatic islets: netrins modulate beta cell apoptosis signalling via dependence receptors. Diabetologia 2011, 54(4):828-842.
3. Amisten S., Salehi A., Rorsman P., Jones P.M., Persaud S.J. An atlas and functional analysis of G-protein coupled receptors in human islets of Langerhans. Pharmacology & Therapeutics 2013, 139(3):359-391.
4. Hauge-Evans A.C., King A.J., Carmignac D., Richardson C.C., Robinson I.C., Low M.J., et al. Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function. Diabetes 2009, 58(2):403-411.
5. Taborsky G.J., Smith P.H., Porte D. Interaction of somatostatin with the A and B cells of the endocrine pancreas. Metabolism 1978, 27(9 Suppl. 1):1299-1302.
6. Brown M., Rivier J., Vale W. Biological activity of somatostatin and somatostatin analogs on inhibtion of arginine-induced insulin and glucagon release in the rat. Endocrinology 1976, 98(2):336-343.
7. van der Meulen T., Donaldson C.J., Caceres E., Hunter A.E., Cowing-Zitron C., Pound L.D., et al. Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion. Nature Medicine 2015, 21(7):769-776.
8. van der Meulen T., Xie R., Kelly O.G., Vale W.W., Sander M., Huising M.O. Urocortin 3 marks mature human primary and embryonic stem cell-derived pancreatic alpha and beta cells. PLoS One 2012, 7(12):e52181.
9. Blum B., Hrvatin S.S., Schuetz C., Bonal C., Rezania A., Melton D.A. Functional beta-cell maturation is marked by an increased glucose threshold and by expression of urocortin 3. Nature Biotechnology 2012, 30(3):261-264.
10. Rozzo A., Meneghel-Rozzo T., Delakorda S.L., Yang S.B., Rupnik M. Exocytosis of insulin: in vivo maturation of mouse endocrine pancreas. Annals of the New York Academy of Sciences 2009, 1152:53-62.
11. Benner C., van der Meulen T., Caceres E., Tigyi K., Donaldson C.J., Huising M.O. The transcriptional landscape of mouse beta cells compared to human beta cells reveals notable species differences in long non-coding RNA and protein-coding gene expression. BMC Genomics 2014, 15(1):620.
12. Dezaki K., Hosoda H., Kakei M., Hashiguchi S., Watanabe M., Kangawa K., et al. Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in beta-cells: implication in the glycemic control in rodents. Diabetes 2004, 53(12):3142-3151.
13. Dezaki K., Damdindorj B., Sone H., Dyachok O., Tengholm A., Gylfe E., et al. Ghrelin attenuates cAMP-PKA signaling to evoke insulinostatic cascade in islet beta-cells. Diabetes 2011, 60(9):2315-2324.
14. Reimer M.K., Pacini G., Ahren B. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology 2003, 144(3):916-921.
15. Tong J., Prigeon R.L., Davis H.W., Bidlingmaier M., Kahn S.E., Cummings D.E., et al. Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans. Diabetes 2010, 59(9):2145-2151.
16. Yada T., Damdindorj B., Rita R.S., Kurashina T., Ando A., Taguchi M., et al. Ghrelin signalling in beta-cells regulates insulin secretion and blood glucose. Diabetes, Obesity and Metabolism 2014, 16(Suppl. 1):111-117.
17. Muller T.D., Nogueiras R., Andermann M.L., Andrews Z.B., Anker S.D., Argente J., et al. Ghrelin. Molecular Metabolism 2015, 4(6):437-460.
18. Huising M.O., van der Meulen T., Vaughan J.M., Matsumoto M., Donaldson C.J., Park H., et al. CRFR1 is expressed on pancreatic beta cells, promotes beta cell proliferation, and potentiates insulin secretion in a glucose-dependent manner. Proceedings of the National Academy of Sciences U S A 2010, 107(2):912-917.
19. Srinivas S., Watanabe T., Lin C.S., William C.M., Tanabe Y., Jessell T.M., et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Developmental Biology 2001, 1:4.
20. Taniguchi H., He M., Wu P., Kim S., Paik R., Sugino K., et al. A resource of Cre driver lines for genetic targeting of GABAergic neurons in cerebral cortex. Neuron 2011, 71(6):995-1013.
21. Herrera P.L. Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development 2000, 127(11):2317-2322.
22. Dobin A., Davis C.A., Schlesinger F., Drenkow J., Zaleski C., Jha S., et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 2013, 29(1):15-21.
23. Liao Y., Smyth G.K., Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 2014, 30(7):923-930.
24. Robinson M.D., McCarthy D.J., Smyth G.K. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010, 26(1):139-140.
25. Xin Y., Kim J., Ni M., Wei Y., Okamoto H., Lee J., et al. Use of the Fluidigm C1 platform for RNA sequencing of single mouse pancreatic islet cells. Proceedings of the National Academy of Sciences U S A 2016, 113(12):3293-3298.
26. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973, 179(4068):77-79.
27. Vale W., Rivier J., Ling N., Brown M. Biologic and immunologic activities and applications of somatostatin analogs. Metabolism 1978, 27(9 Suppl. 1):1391-1401.
28. Reubi J.C., Schaer J.C., Wenger S., Hoeger C., Erchegyi J., Waser B., et al. SST3-selective potent peptidic somatostatin receptor antagonists. Proceedings of the National Academy of Sciences U S A 2000, 97(25):13973-13978.
29. Mulder H., Lindh A.C., Sundler F. Islet amyloid polypeptide gene expression in the endocrine pancreas of the rat: a combined in situ hybridization and immunocytochemical study. Cell and Tissue Research 1993, 274(3):467-474.
30. Artner I., Hang Y., Mazur M., Yamamoto T., Guo M., Lindner J., et al. MafA and MafB regulate genes critical to beta-cells in a unique temporal manner. Diabetes 2010, 59(10):2530-2539.
31. Zhang J., McKenna L.B., Bogue C.W., Kaestner K.H. The diabetes gene Hhex maintains delta-cell differentiation and islet function. Genes & Development 2014, 28(8):829-834.
32. Petri A., Ahnfelt-Ronne J., Frederiksen K.S., Edwards D.G., Madsen D., Serup P., et al. The effect of neurogenin3 deficiency on pancreatic gene expression in embryonic mice. Journal of Molecular Endocrinology 2006, 37(2):301-316.
33. Su Y., Jono H., Misumi Y., Senokuchi T., Guo J., Ueda M., et al. Novel function of transthyretin in pancreatic alpha cells. FEBS Letters 2012, 586(23):4215-4222.
34. Alexander S.P., Mathie A., Peters J.A. Guide to receptors and channels (GRAC), 5th edition. British Journal of Pharmacology 2011, 164(Suppl. 1):S1-S324.
35. Chen T.W., Wardill T.J., Sun Y., Pulver S.R., Renninger S.L., Baohan A., et al. Ultrasensitive fluorescent proteins for imaging neuronal activity. Nature 2013, 499(7458):295-300.
36. Braun M., Ramracheya R., Amisten S., Bengtsson M., Moritoh Y., Zhang Q., et al. Somatostatin release, electrical activity, membrane currents and exocytosis in human pancreatic delta cells. Diabetologia 2009, 52(8):1566-1578.
37. Schaffer A.E., Taylor B.L., Benthuysen J.R., Liu J., Thorel F., Yuan W., et al. Nkx6.1 controls a gene regulatory network required for establishing and maintaining pancreatic Beta cell identity. PLoS Genetics 2013, 9(1):e1003274.
38. Salehi A., Qader S.S., Grapengiesser E., Hellman B. Pulses of somatostatin release are slightly delayed compared with insulin and antisynchronous to glucagon. Regulatory Peptides 2007, 144(1-3):43-49.
39. Gauna C., van de Zande B., van Kerkwijk A., Themmen A.P., van der Lely A.J., Delhanty P.J. Unacylated ghrelin is not a functional antagonist but a full agonist of the type 1a growth hormone secretagogue receptor (GHS-R). Molecular and Cellular Endocrinology 2007, 274(1-2):30-34.
40. Tong J., Davis H.W., Summer S., Benoit S.C., Haque A., Bidlingmaier M., et al. Acute administration of unacylated ghrelin has no effect on basal or stimulated insulin secretion in healthy humans. Diabetes 2014, 63(7):2309-2319.
41. Kageyama H., Funahashi H., Hirayama M., Takenoya F., Kita T., Kato S., et al. Morphological analysis of ghrelin and its receptor distribution in the rat pancreas. Regulatory Peptides 2005, 126(1-2):67-71.
42. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I., et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996, 273(5277):974-977.
43. Dezaki K., Kakei M., Yada T. Ghrelin uses Galphai2 and activates voltage-dependent K+ channels to attenuate glucose-induced Ca2+ signaling and insulin release in islet beta-cells: novel signal transduction of ghrelin. Diabetes 2007, 56(9):2319-2327.
44. Chuang J.C., Sakata I., Kohno D., Perello M., Osborne-Lawrence S., Repa J.J., et al. Ghrelin directly stimulates glucagon secretion from pancreatic alpha-cells. Molecular Endocrinology 2011, 25(9):1600-1611.
45. Samols E., Marri G., Marks V. Promotion of insulin secretion by glucagon. Lancet 1965, 2(7409):415-416.
46. Samols E., Marri G., Marks V. Interrelationship of glucagon, insulin and glucose. The insulinogenic effect of glucagon. Diabetes 1966, 15(12):855-866.
47. Park S., Jiang H., Zhang H., Smith R.G. Modification of ghrelin receptor signaling by somatostatin receptor-5 regulates insulin release. Proceedings of the National Academy of Sciences U S A 2012, 109(46):19003-19008.
48. Kurashina T., Dezaki K., Yoshida M., Sukma Rita R., Ito K., Taguchi M., et al. The beta-cell GHSR and downstream cAMP/TRPM2 signaling account for insulinostatic and glycemic effects of ghrelin. Scientific Reports 2015, 5:14041.
49. Granata R., Settanni F., Biancone L., Trovato L., Nano R., Bertuzzi F., et al. Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling. Endocrinology 2007, 148(2):512-529.
50. Egido E.M., Rodriguez-Gallardo J., Silvestre R.A., Marco J. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. European Journal of Endocrinology 2002, 146(2):241-244.